Berkshire Hathaway, Cisco And A Health Care Stock: CNBC’s ‘Final Trades’

LongbridgeAII'm LongbridgeAI. Here is the key information I extracted
- Jim Lebenthal, Jenny Van Leeuwen Harrington, and Joseph M. Terranova shared their stock picks on CNBC's Final Trades, featuring Berkshire Hathaway, Cisco Systems, and Eli Lilly.
- Berkshire Hathaway saw portfolio adjustments under CEO Greg Abel, while Cisco reported strong first-quarter results and raised its fiscal year 2027 revenue guidance to a range of $74.8 billion to $75.8 billion.…
Disclaimer

On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal, partner and chief market strategist at Cerity Partners, picked Berkshire Hathaway Inc. (NYSE:BRK).

On Oct. 22, UBS analyst Brian Meredith maintained a Buy rating on Berkshire Hathaway and raised the price target from $604 to $628.

The company, once led by Warren Buffett, made several changes to its portfolio under new CEO Greg Abel. For example, Berkshire Hathaway recently unveiled a new position in Bending Spoons (NASDAQ:BSP), which owns AOL, Eventbrite, NetScape, Streamyard, Vimeo and Airtable.

Cisco Boasts a 5% Free Cash Flow Yield

Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, said Cisco Systems, Inc. (NASDAQ:CSCO) has a 5% free cash flow yield.

On the earnings front, Cisco reported better-than-expected first-quarter financial results on Nov. 12 and raised its FY27 guidance.

The company boosted its fiscal year 2027 revenue guidance from a range of $72.2 billion to $73.4 billion to a new range of $74.8 billion to $75.8 billion, versus estimates of $73.02 billion. The company also raised its full-year adjusted earnings outlook from a range of $5.05 to $5.11 per share to a new range of $5.47 to $5.53 per share, versus estimates of $5.11 per share.

Don’t forget to check out our premarket coverage here

Joseph M. Terranova, senior managing director for Virtus Investment Partners, said Eli Lilly and Company (NYSE:LLY) continues to move higher.

Eli Lilly on Monday agreed to acquire Calytrix Bio Inc. for up to $1.5 billion in cash. Under the deal terms, Calytrix shareholders stand to receive an upfront cash payment plus additional payments upon meeting clinical and regulatory milestones.

Price Action

  • Berkshire Hathaway shares slipped 0.02% to close at $592.85 on Monday.
  • Cisco shares declined 1.2% to close at $94.52.
  • Eli Lilly shares fell 0.8% to settle at $1,431.67 during the session.

See More: Top Value Stocks

Photo via Shutterstock

Login to unlock1,152characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.